Pooled Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, Across Two Phase 3 Trials: CORALreef Lipids and CORALreef HeFH

Journal of clinical lipidology 2026

View at publisher
Authors: Christie Ballantyne, Elina Mikhailova, Alberico Catapano, Dirk Blom, Emil Asprusten, Puja Banka, ALBERTO CADENA, Samar Froman, LAURA GELLIS, MYEONGJONG KANG, Susan Kourpanidis, Norman Lepor
+2 more Geraldine Mendizabal, Julio Nunez
DOI: 10.1016/j.jacl.2026.05.188
Cited by: 1

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Medication Adherence and Compliance Diabetes Treatment and Management

Publication details

Journal / source
Journal of clinical lipidology
Publisher
Elsevier BV
Volume
20
Issue
6
Pages
e121–e122
Publication date
1 June 2026
Language
EN